Diagnostic testing for mild hemophilia A in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 3, 2013, Pages 272-282

  Duncan, Elizabeth M ^a   Rodgers, Susan E ^a   McRae, Simon J ^a  

^a Haematology Division   (Australia)

Author keywords

assay methods; discrepant; factor VIII; hemophilia A

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ACCURACY; ARTICLE; CHROMOGENEIC ASSAY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HEMOPHILIA A; HUMAN; LABORATORY; MISSENSE MUTATION; ONE STAGE CLOTTING ASSAY; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; TOTAL QUALITY MANAGEMENT; TWO STAGE CLOTTING ASSAY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; MALE;

EID: 84875446181     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1334863     Document Type: Article

References (41)

1. Preston F. E., Kitchen S., Jennings I., Woods T. A., Makris M. SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria? J Thromb Haemost: 2004; 2 2 271 274 (Pubitemid 40186041)
2. Kitchen S., Hayward C., Negrier C., Dargaud Y. New developments in laboratory diagnosis and monitoring. Haemophilia: 2010; 16 05 61 66
3. Mackie I., Cooper P., Lawrie A., Kitchen S., Gray E., Laffan M. British Committee for Standards in Haematology Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol: 2013; 35 1 1 13
4. Parquet-Gernez A., Mazurier C., Goudemand M. Functional and immunological assays of FVIII in 133 haemophiliacs-characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thromb Haemost: 1988; 59 2 202 206
5. Duncan E. M., Duncan B. M., Tunbridge L. J., Lloyd J. V. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. Br J Haematol: 1994; 87 4 846 848 (Pubitemid 24264662)
6. Rudzki Z., Duncan E. M., Casey G. J., Neumann M., Favaloro E. J., Lloyd J. V. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol: 1996; 94 2 400 406 (Pubitemid 26248003)
7. Mazurier C., Gaucher C., Jorieux S., Parquet-Gernez A. Mutations in the FVIII gene in seven families with mild haemophilia A. Br J Haematol: 1997; 96 2 426 427 (Pubitemid 27077387)
8. Keeling D. M., Sukhu K., Kemball-Cook G., Waseem N., Bagnall R., Lloyd J. V. Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954-> Leu substitution in the factor VIII A3 domain. Br J Haematol: 1999; 105 4 1123 1126 (Pubitemid 29309127)
9. Pipe S. W., Eickhorst A. N., McKinley S. H., Saenko E. L., Kaufman R. J. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood: 1999; 93 1 176 183 (Pubitemid 29019401)
10. Pipe S. W., Saenko E. L., Eickhorst A. N., Kemball-Cook G., Kaufman R. J. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood: 2001; 97 3 685 691 (Pubitemid 32113401)
11. Lyall H., Hill M., Westby J., Grimley C., Dolan G. Tyr346-> Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A? Haemophilia: 2008; 14 1 78 80
12. Lippi G., Franchini M., Favaloro E. J. One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin. Blood Coagul Fibrinolysis: 2009; 20 1 1 3
13. Denson K. WE, Biggs R. Laboratory diagnosis - tests of clotting function and their standardization. In: Biggs R., ed. Human Blood Coagulation, Haemostasis and Thrombosis. Oxford Blackwell Scientific Publications: 1976; 310 364
14. Hathaway W. E., Christian M. J., Jacobson L. J. Variant mild haemophilia. Discrepancy in one stage and two stage factor VIII assays. Thromb Haemost: 1983; 50 357 (abstract 1123)
15. Schwaab R., Oldenburg J., Kemball-Cook G., et al. Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. Br J Haematol: 2000; 109 3 523 528 (Pubitemid 30415176)
16. Hill M., Deam S., Gordon B., Dolan G. Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype. Haemophilia: 2005; 11 2 133 141 (Pubitemid 40468061)
17. Lucía J. F., Aguilar C., Dobon M., et al. Discrepant factor VIII activity in a family with mild haemophilia A and 531 mutation using various FVIII assays and APTT reagents. Haemophilia: 2005; 11 5 561 564 (Pubitemid 41283129)
18. Cid A. R., Calabuig M., Cortina V., et al. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia: 2008; 14 5 1049 1054
19. Poulsen A. L., Pedersen L. H., Hvas A. M., Poulsen L. H., Thykjaer H., Ingerslev J. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre. Haemophilia: 2009; 15 1 285 289
20. Kemball-Cook G. Haemophilia A Database (also known as HAMSTERs). Available at: www.hadb.org.uk. Accessed August 2012
21. Rodgers S. E., Duncan E. M., Barbulescu D. M., Quinn D. M., Lloyd J. V. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results. Br J Haematol: 2007; 136 1 138 145 (Pubitemid 44912600)
22. Rodgers S. E., Duncan E. M., Sobieraj-Teague M., Lloyd J. V. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A. Int J Lab Hematol: 2009; 31 2 180 188
23. Favaloro E. J., Soltani S., McDonald J., Grezchnik E., Easton L. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis: 2005; 16 8 597 605 (Pubitemid 41658981)
24. Bonar R., Favaloro E. J., Adcock D. M. Quality in coagulation and haemostasis testing. Biochem Med (Zagreb): 2010; 20 2 184 199
25. Cunningham M. T., Brandt J. T., Chandler W. L., et al. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost: 2007; 33 3 250 258 (Pubitemid 46581379)
26. Verbruggen B., Meijer P., Novákova I., Van Heerde W. Diagnosis of factor VIII deficiency. Haemophilia: 2008; 14 03 76 82 (Pubitemid 351722387)
27. Westgard J. O. What's the idea behind statistical quality control? In: Basic QC Practices. 3rd ed. Madison, WI Westgard QC Inc: 2010; 15 26
28. Westgard J. O. How is the imprecision of a method determined? In: Basic Method Validation. 2nd ed. Madison, WI Westgard QC Inc: 2003; 101 110
29. National Pathology Accreditation Advisory Council (NPAAC) Requirements for the estimation of measurement uncertainty (2007 edition). Available at: www.health.gov.au/npaac. Accessed September 2012
30. Sobas F., Mazliak L., Bellisario A., et al. Determining the adequate number of internal quality control levels: the example of coagulation factor VIII assay. Blood Coagul Fibrinolysis: 2008; 19 5 433 437
31. Sobas F., Benattar N., Bellisario A., et al. Impact of quality control matrix effect: application to the calculation of uncertainty of measurement in one-stage clotting factor VIII assay. Blood Coagul Fibrinolysis: 2010; 21 5 498 501
32. Kleinveld H. A., Andersson N. E., van Voorthuizen H., den Hartog J., de Groot P. G. Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer. Scand J Clin Lab Invest: 1999; 59 5 335 341
33. Denson K. WE, Wilkins T. Semi-automation of the two-stage factor VIII assay. Clin Lab Haematol: 1980; 2 311 316 (Pubitemid 11210620)
34. Barrowcliffe T. W. Comparisons of one-stage and two-stage assays of factor VIII:C. Scand J Haematol Suppl: 1984; 41 41 39 54 (Pubitemid 15207069)
35. Mainwaring C. J., Evans J., Chana J., Lewis H. Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period. Haemophilia: 2006; 12 6 668 671 (Pubitemid 44697540)
36. Gilmore R., Harmon S., Gannon C., Byrne M., O'Donnell J. S., Jenkins P. V. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy. Haemophilia: 2010; 16 4 671 674
37. Trossaërt M., Regnault V., Sigaud M., Boisseau P., Fressinaud E., Lecompte T. Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype. J Thromb Haemost: 2008; 6 3 486 493 (Pubitemid 351280117)
38. Bowyer A. E., Goodeve A., Liesner R., Mumford A. D., Kitchen S., Makris M. P. Tyr365Cys change in factor VIII: haemophilia A, but not as we know it. Br J Haematol: 2011; 154 5 618 625
39. Beltrán-Miranda C. P., Khan A., Jaloma-Cruz A. R., Laffan M. A. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia: 2005; 11 4 326 334 (Pubitemid 41030831)
40. Lippi G., Salvagno G. L., Montagnana M., Lima-Oliveira G., Guidi G. C., Favaloro E. J. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost: 2012; 38 6 565 575
41. Rodgers S. E., Lerda N. V., Favaloro E. J., et al. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods. Am J Clin Pathol: 2002; 118 2 269 276 (Pubitemid 44698454)